Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $947,040 - $1.68 Million
8,000 Added 30.36%
34,349 $6.17 Million
Q3 2022

Nov 08, 2022

BUY
$118.07 - $194.18 $738,409 - $1.21 Million
6,254 Added 31.12%
26,349 $3.12 Billion
Q1 2022

Apr 28, 2022

BUY
$126.46 - $235.05 $2.54 Million - $4.72 Million
20,095 New
20,095 $3.46 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Value Star Asset Management (Hong Kong) LTD Portfolio

Follow Value Star Asset Management (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Value Star Asset Management (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Value Star Asset Management (Hong Kong) LTD with notifications on news.